Xiaomian Li
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosis.
Journal: Nature communications
Published: November 27, 2025
CCT2 Orchestrates Glycolysis and Exosome-Mediated M2 Macrophage Polarization in HCC tumorigenesis.
Journal: International journal of biological sciences
Published: July 31, 2025
CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models.
Journal: JHEP reports : innovation in hepatology
Published: April 21, 2025
PP1A Modulates the Efficacy of Lenvatinib Plus ICIs Therapy by Inhibiting Ferroptosis in Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 26, 2025
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 08, 2025
ADH1C maintains the homeostasis of metabolic microenvironment to inhibit steatotic hepatocellular carcinoma.
Journal: Metabolism: clinical and experimental
Published: October 31, 2024
LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemia.
LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemia.
Journal: Hepatology (Baltimore, Md.)
Published: June 14, 2023
Last Updated: 09/26/2026